Table 4.
Between-group changes in primary and secondary outcomes.
| Outcomes | eMotion | Control group | Adjusted mean differencea (95% CI) | |||
|
|
N | Mean (SD) | N | Mean (SD) |
|
|
| Depression (PHQ-8b) |
|
|
|
|
||
|
|
Baseline | 32 | 14.4 (3.4) | 30 | 14.8 (2.9) |
|
|
|
2 months postrandomization | 25 | 8.7 (4.8) | 25 | 12.9 (4.2) | −3.6 (−6.1 to −1.1) |
| Anxiety (GAD-7c) |
|
|
|
|
|
|
|
|
Baseline | 31 | 10.1 (5.4) | 27 | 12.0 (4.7) |
|
|
|
2 months postrandomization | 25 | 7.1 (3.8) | 25 | 10.9 (3.7) | −3.3 (−5.4 to −1.2) |
| Min per week of objective MVPA in 10-min boutsd |
|
|
|
|
||
|
|
Baseline | 27 | 29.5 (0.0 to 8.8) | 25 | 42.1 (8.1 to 93.7) |
|
|
|
2 months postrandomization | 13 | 97.6 (49.7 to 166.3) | 11 | 13.0 (0.0 to 131.4) | 16.4 (−43.7 to 76.5) |
| IPAQ-SF daily minutes of MVPAd |
|
|
|
|
|
|
|
|
Baseline | 27 | 12.9 (0.0 to 25.7) | 20 | 10.7 (3.6 to 17.9) |
|
|
|
2 months postrandomization | 19 | 11.4 (4.3 to 25.7) | 14 | 15.7 (0.0 to 22.9) | 0.2 (−8.7 to 9.2) |
aMultiple regression adjusted for baseline value and confidence intervals reported.
bPHQ-8: Patient Health Questionnaire 8.
cGAD-7: General Anxiety Disorder scale.
dAs physical activity data were skewed, medians and interquartile ranges (IQR) are presented, and analysis was repeated using bootstrapping.